drug · antibody

prasinezumab

Phase 3updated 5mo ago

by Prothena Corp Plc🔗 ChEMBL

Phase 3

community read0 votes

Antibody drug with a maximum clinical stage of Phase 3, with 1 investigational indication.

indications

Parkinson's Disease

targets

Alpha-synuclein

all catalysts(0)

nothing on the calendar yet

Trials studying prasinezumab

phase3A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Diseaserecruitingn=900
phase2A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Diseaseactive not recruitingn=586

News(1)

Reeling from past failures, Parkinson's pipeline enters 'era of diversification'
While some drugmakers continue to walk the alpha-synuclein antibody path, others like AC Immune opt for new approaches that could bring the first-ever disease-modifying therapy for Parkinson's dise…
biospace · 25d ago

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 1h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug · antibody

save

prasinezumab

Phase 3updated 5mo ago

by Prothena Corp Plc🔗 ChEMBL

Phase 3

community read0 votes

Antibody drug with a maximum clinical stage of Phase 3, with 1 investigational indication.

indications

Parkinson's Disease

targets

Alpha-synuclein

all catalysts(0)

nothing on the calendar yet

Trials studying prasinezumab

phase3A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Diseaserecruitingn=900
phase2A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Diseaseactive not recruitingn=586

News(1)

Reeling from past failures, Parkinson's pipeline enters 'era of diversification'
While some drugmakers continue to walk the alpha-synuclein antibody path, others like AC Immune opt for new approaches that could bring the first-ever disease-modifying therapy for Parkinson's dise…
biospace · 25d ago

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 1h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

prasinezumab

indications

targets

all catalysts(0)

Trials studying prasinezumab

News(1)

Report a data issue

comments(0)

prasinezumab

indications

targets

all catalysts(0)

Trials studying prasinezumab

News(1)

Report a data issue

comments(0)